Verification test of Moisturizing effect for patients with atopic dermatitis.

Placebo-controlled, double-blind, randomized controlled trials that verify moisturizing effect of patients with atopic dermatitis by lotion containing plant extract. - Placebo-controlled, double-blind, randomized controlled trials that verify moisturizing effect.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041829

Enrollment

Registered

2020-09-18

Start date

2020-09-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Continuous application for 12-weeks two types of the moisturizing lotion (Placebo on the left, Lotion containing plant extract on the right). Continuous application for 12-weeks two types of the moist

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Individuals with mild atopic dermatitis. 2)Individuals with dryness on the inside of the left and right forearms. 3)Individuals who agree to participate in this test after understanding the explanation of exam and show willingness to participate in the exam.

Exclusion criteria

Exclusion criteria: 1)Individuals with moderate or higher atopic dermatitis. 2)Individuals who are taking orally steroids, antihistamine, anti-allergic agent, immunosuppressant, tranquilizers. 3)Individuals who have serious allergy by the use of topical drugs, cosmetics, quasi drugs and others in the past. 4)Individuals considered to be inappropriate for inclusion to have a serious illness. 5)Individuals who are being treated or hospitalized due to illness (Excluding colds and dentistry). 6)Individuals who have a family that are working at Pharmaceutical company or cosmetic company. 7)Individuals who are currently participating on survey using foods, cosmetics and quasi drugs, or are participating on any other clinical study, or have done so in the previous four weeks. 8)Individuals who are regarded to be inappropriate for this study by doctors.

Design outcomes

Primary

Measure	Time frame
Stratum corneum water content	—

Secondary

Measure	Time frame
Skin observation by doctor Transepidermal water loss Microscope photography Collecting stratum corneum	—

Countries

Japan

Contacts

Public ContactTakanori Inai

FUJI-SANGYO CO.,LTD Research and Development Laboratory

inai@fuji-sangyo.co.jp0877-25-3221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026